AU2003206442A1 - Estrogenic component for treating decreased libido in women - Google Patents

Estrogenic component for treating decreased libido in women

Info

Publication number
AU2003206442A1
AU2003206442A1 AU2003206442A AU2003206442A AU2003206442A1 AU 2003206442 A1 AU2003206442 A1 AU 2003206442A1 AU 2003206442 A AU2003206442 A AU 2003206442A AU 2003206442 A AU2003206442 A AU 2003206442A AU 2003206442 A1 AU2003206442 A1 AU 2003206442A1
Authority
AU
Australia
Prior art keywords
women
decreased libido
estrogenic component
treating decreased
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003206442A
Inventor
Herman Jian Tijmen Coelingh Bennink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantarhei Bioscience BV
Original Assignee
Pantarhei Bioscience BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience BV filed Critical Pantarhei Bioscience BV
Publication of AU2003206442A1 publication Critical patent/AU2003206442A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
AU2003206442A 2002-02-21 2003-02-19 Estrogenic component for treating decreased libido in women Abandoned AU2003206442A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075696 2002-02-21
EP02075696.1 2002-02-21
PCT/NL2003/000125 WO2003070253A1 (en) 2002-02-21 2003-02-19 Estrogenic component for treating decreased libido in women

Publications (1)

Publication Number Publication Date
AU2003206442A1 true AU2003206442A1 (en) 2003-09-09

Family

ID=27741183

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003206442A Abandoned AU2003206442A1 (en) 2002-02-21 2003-02-19 Estrogenic component for treating decreased libido in women

Country Status (2)

Country Link
AU (1) AU2003206442A1 (en)
WO (1) WO2003070253A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3205648A1 (en) 2010-06-10 2017-08-16 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
EP2791133B1 (en) 2011-12-14 2019-04-17 Seragon Pharmaceuticals, Inc. Fluorinated estrogen receptor modulators and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434697T2 (en) * 1993-01-19 2007-03-29 Endorecherche Inc., Ste-Foy Therapeutic uses of dehydroepiandrosterone for the treatment of decreased libido and osteoporosis
US5439931A (en) * 1993-12-21 1995-08-08 Eli Lilly And Company Method for increasing libido in post-menopausal women
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
WO1998033499A1 (en) * 1997-01-29 1998-08-06 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for increasing libido in post-menopausal women
CO4940467A1 (en) * 1997-06-27 2000-07-24 Smithkline Beecham Corp NEW METHODS
KR100679735B1 (en) * 1998-06-11 2007-02-07 앙도르쉐르슈 인코포레이티드 Pharmaceutical compositions and uses for androst-5-ene-3?,17?-diol

Also Published As

Publication number Publication date
WO2003070253A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
AU2003284242A1 (en) Methods and compositions for use in treating cancer
EP2671581B8 (en) Compositions and methods for treating cancer
AU2003230750A1 (en) Compositions and methods for treating cancer
AU2003291356A1 (en) Methods and compositions for treating cancer using proteasome inhibitors
AU2002340120A1 (en) Semisolid topical hormonal compositions and methods for treatment
HK1072360A1 (en) Compositions for use in methods for treating hearing loss
EP1468118A4 (en) Methods and compositions for treating cancer
EP1589990A4 (en) Method for treating cancer in humans
EP1680073A4 (en) Compounds and method for treating cancer
AU2003287443A1 (en) Compositions and methods for pain reduction
EP1572118A4 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
PL370457A1 (en) New corticosteroids
AU2003232044A8 (en) Composition and method for dermatological treatment
GB2402308B (en) Par reduction for edge clipper
EP1626711A4 (en) Compositions and methods for treating cancer
AU2003262840A1 (en) Composition and method for treating skin
AU2003238905A1 (en) Surface treating compositions and methods for using same
HUP0600855A2 (en) Androgen pharmaceutical composition for treating depression
AU2003206442A1 (en) Estrogenic component for treating decreased libido in women
AU2003225461A8 (en) Composition and method for supporting cancer treatments
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
AU2001238179A1 (en) Method and compositions for treating hepatocellular cancer
AU2003275433A1 (en) Compositions and methods for treating pain
AU2002303237A1 (en) Combined hydrotreating process and configurations for same
EP1599214A4 (en) Methods and compositions for treating cervical cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase